ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search
  • 2021 American Transplant Congress

    Impact of Insulin Therapy in Pancreas Transplantation Donors on Graft Outcomes: An Analysis of the Optn/unos Database

    E. Montagud-Marrahi1, F. Ausania2, Y. Fundora2, A. Amor3, E. Esmatjes3, J. Ferrer2, I. Revuelta1, D. Cucchiari1, J. Rovira4, M. Musquera5, C. Fondevila2, F. Diekmann1, P. Ventura-Aguiar1

    1Nephrology and Kidney Transplantation Department, Hospital Clinic de Barcelona, Barcelona, Spain, 2Hepatobiliopancreatic and Liver Transplant Department, Hospital Clinic de Barcelona, Barcelona, Spain, 3Endocrinology Department, Hospital Clinic de Barcelona, Barcelona, Spain, 4Laboratori Experimental de Nefrologia I Trasplantament (LENIT), CRB CELLEX, Fundació Clínic, IDIBAPS, Hospital Clinic de Barcelona, Barcelona, Spain, 5Urology Department, Hospital Clinic de Barcelona, Barcelona, Spain

    *Purpose: Hyperglycemia requiring insulin treatment is frequent in critically ill patients and potential pancreas donors. Information on the impact of donor insulin use on pancreas…
  • 2021 American Transplant Congress

    Baseline Levels of Dd-cf Dna After Pancreas Transplantation: Using Dd-cfdna as an Indicator for Pancreas Rejection and Biopsy Avoidance

    A. Yoo, I. Qian, A. Riedel, C. Cazac, A. Bartosic, J. S. Bromberg, J. Scalea

    Department of Surgery, Division of Transplant, University of Maryland School of Medicine, Baltimore, MD

    *Purpose: Donor-derived cell-free DNA (dd-cfDNA) testing, which has been previously validated for monitoring kidney transplant (KTx) rejection, may provide an alternative to pancreas biopsy that…
  • 2021 American Transplant Congress

    The Use of Organs from Donors That Do Not Meet Eligibility Criteria in the United States

    L. Deroos, M. Lavieri, D. Hutton, W. Marrero, N. Parikh

    University of Michigan, Ann Arbor, MI

    *Purpose: Increasing the number of organs available for transplantation could reduce waitlist morbidity and mortality for patients with end organ failure. Most transplanted organs come…
  • 2021 American Transplant Congress

    SARS-CoV-2 Infection in Solid Organ Transplant Recipients: A Retrospective Cohort Study

    A. Adeel

    Infectious Diseases, University of Massachusetts, Worcester, MA

    *Purpose: Initial studies of COVID-19 in solid organ transplant (SOT) recipients demonstrated high mortality rates, but more recent comparative data shows contradictory results.*Methods: We evaluated…
  • 2021 American Transplant Congress

    Impact of Covid-19 Infection on Tacrolimus Levels in Solid Organ Transplant Recipients

    K. Heagler, K. Tejani, S. Sanchez

    Loyola University Medical Center, Maywood, IL

    *Purpose: Immunocompromised patients are considered to be at high-risk for infection with SARS-CoV-2 (COVID-19). There have been observations within the transplant community that patients infected…
  • 2021 American Transplant Congress

    Immunosuppression in Uterine Transplant Recipients: Experience from the Largest Uterine Transplant Program

    N. Wilson, R. Patel, L. Johannesson, G. Testa, T. Sam

    Baylor University Medical Center at Dallas, Dallas, TX

    *Purpose: Uterus transplantation (UT) is an emerging treatment in the field of total uterine infertility. There is no consensus on the optimal immunosuppression regimen in…
  • 2021 American Transplant Congress

    Development and Durability of Sars-cov-2 Antibodies Among Solid Organ Transplant Recipients

    B. Boyarsky, M. Ou, R. Greenberg, M. Krach, R. Wang, T. P. Chiang, W. Werbel, R. Avery, W. Clarke, A. Tobian, A. Massie, D. Segev, J. Garonzik-Wang

    Johns Hopkins, Baltimore, MD

    *Purpose: The response to SARS-CoV-2 may be blunted in transplant recipients, impacting reinfection risk, treatment selection, and vaccine protocols. We quantified antibody response and durability…
  • 2021 American Transplant Congress

    Trends in Liver Donors for Liver Transplantation Over Twenty Years: Donor Changes in Gender, Relationships, and Education, but Racial Disparities Remain

    A. Kaplan, B. Fortune, R. Brown, MD, MPH, B. Samstein, K. Halazun, R. Rosenblatt

    Gastroenterology and Hepatology, New York Presbyterian/Weill Cornell, New York, NY

    *Purpose: Living donor liver transplant (LDLT) has grown over the past several decades as a response to critical organ shortages. Racial and ethnic disparities exist…
  • 2021 American Transplant Congress

    Outcomes of Simultaneous Pancreas-Kidney Transplants from Donation After Circulatory Death Donors in the UK: A National Registry Analysis

    N. Karydis1, M. Ibrahim2, C. Counter2, J. Casey3, P. Friend4, C. Watson5, C. Callaghan1

    1Nephrology and Transplantation, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom, 2NHS Blood and Transplant, Bristol, United Kingdom, 3Transplant Unit, Royal Infirmary of Edinburgh, Edinburgh, United Kingdom, 4Nuffield Department of Surgical Sciences, University of Oxford, Oxford, United Kingdom, 5Department of Surgery, Addenbrooke's Hospital and Cambridge NIHR Biomedical Research Campus, Cambridge, United Kingdom

    *Purpose: The UK is a world leader in the use of pancreases from donation after circulatory death (DCD) donors. However, there is a perception that…
  • 2021 American Transplant Congress

    Growth Differentiation Factor 15 Predictor Value is Superior to Troponin I in the Evaluation of Kidney Transplant Candidates

    M. de Cos Gomez1, M. Garcia Unzueta2, A. Benito Hernandez1, J. Mazon Ruiz1, M. Perez Arnedo1, A. Aguilera Fernandez1, R. Valero San Cecilio1, J. Ruiz San Millan1, E. Rodrigo Calabia1

    1Nephrology, Marques de Valdecilla University Hospital - IDIVAL, Santander, Spain, 2Clinical Analysis, Marques de Valdecilla University Hospital - IDIVAL, Santander, Spain

    *Purpose: Pretransplant cardiac troponin I (cTNI) has demonstrated its predictor value of survival after kidney transplant in previous studies. Growth differentiation factor 15 (GDF-15) is…
  • « Previous Page
  • 1
  • …
  • 118
  • 119
  • 120
  • 121
  • 122
  • …
  • 139
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences